Posts Tagged ‘OHSU in the news’

This afternoon, OHSU announced a $125 million gift from Nike co-founder and Chairman Phil Knight and his wife Penny that will establish a new cardiovascular institute at OHSU. This is the Knights’ second landmark gift to OHSU–in 2008 they gave $100 million to fund the OHSU Knight Cancer Institute–and the largest in OHSU history. Under the leadership of Albert Starr, M.D., co-inventor of the world’s first successful heart valve, and Sanjiv Kaul, M.D., an innovator … Read More

In 2011, OHSU’s Mother-Baby Unit stopped routine distribution of pacifiers to breastfeeding newborns in accordance with recommendations by the Joint Commission and the American Academy of Pediatrics. Their goal was to increase the number of infants in the unit who were breastfed only and received no supplemental formula. What happened, though, was quite the opposite. When the no-pacifier policy was implemented, the percent of exclusively breastfed infants dropped from 79 to 68 percent. During the … Read More

According to a study by lead author Erick Turner, M.D., assistant professor of psychiatry and pharmacology, physicians who prescribe antipsychotic medications may be doing so based on incomplete information. Dr. Turner and his colleagues found that while overall, antipsychotic medications appear to be more effective than placebos in clinical trials, sometimes the results of these studies are not published, or articles are written in such a way that overstates a drug’s effectiveness. For example, there … Read More

Don’t miss the op-ed in today’s print and online editions of The Oregonian, written by Mark Richardson, M.D., Dean of the School of Medicine, and Dan Dorsa, Ph.D., Vice President for Research. In the article, Drs. Richardson and Dorsa argue that federal funding for biomedical research is vital to both Oregon’s health and economy. Do you agree? Share the article with your friends and family. View the article on OregonLive.com.

Brian Druker, M.D., head of OHSU’s Knight Cancer Institute, has been awarded the prestigious 2012 Japan Prize in Healthcare and Medical Technology for pioneering the development of targeted cancer drugs. Dr. Druker shares the Japan Prize with two other scientists who have revolutionized the way we think about cancer treatment: Nicholas B. Lydon, Ph.D., founder and director of Blueprint Medicines, and Janet D. Rowley, M.D., Blum-Riese Distinguished Service Professor of Medicine, Molecular Genetics & Cell … Read More

You’ve been hearing it for years: eat more fruits and veggies, and replace red meat with omega-3-rich fish like salmon. A new study by Gene Bowman, N.D., M.P.H., assistant professor of neurology, showed that people with higher intake of B vitamins, vitamins C, D, E, and omega 3 fatty acids, had less brain shrinkage (which is associated with Alzheimer’s disease) and higher mental acuity than those who were vitamin deficient. Another interesting finding: the study … Read More

OHSU researchers have been getting quite a bit of media attention because of next week’s World Congress on the Developmental Origins of Health and Disease (DOHaD) in Portland. Here are some highlights you don’t want to miss: On Friday, September 16, OHSU announced a $25 million donation by Bob and Charlee Moore, founders of Bob’s Red Mill Natural Foods. The Moore’s donation will support research, policy, and public outreach related to the health effects of … Read More

An estimated one in three adults in the U.S. is obese, but its treatment may be more complex than you might think, according to OHSU’s Kevin Grove, PhD, who has been featured in the New York Times and on ABC’s Nightline for his research on obesity and diabetes in “couch-potato” primates. Since we blogged about Dr. Grove’s research back in February, OHSU’s communications team has created a fact sheet about obesity and OHSU’s research on … Read More

Members of OHSU’s research community have asked us to share this special event with readers of Research News: Aiming toward full recovery of the tsunami-affected area in Japan: Perspectives of OHSU MDs from their recent relief efforts March 11, 2011. The day Japan shook. It changed everything. The massive earthquake and following tsunami engulfed thousands of lives. We have heard many heartbreaking stories, cries, and tears. It has been almost two months. While news coverage … Read More

In an article published earlier today, OHSU’s Lynn A. Jansen, RN, PhD (left), associate director of the Center for Ethics in Health Care, talks with the New York Times about the dangers of unrealistic optimism for early-phase clinical trial patients. Dr. Jensen is lead author on a recent paper describing how cancer patients significantly overestimate the likelihood a clinical trial will improve their health in comparison to other participants in the same trial. According to … Read More